Clinical efficacy of nanohydroxyapatite-containing toothpaste at relieving dentin hypersensitivity: an 8 weeks randomized control trial.

Bennett Tochukwu AmaechiKelly C LemkeShyamali SahaMinh N LuongJonathan Gelfond

Published in: BDJ open (2021)

Toothpaste containing nano-HAP (10 or 15%) alone or supplemented with KNO3 was as effective as CSPS for relief of DHS symptoms when used at least twice daily.

Keyphrases

double blind
open label
placebo controlled
phase iii
phase ii
physical activity
drug induced
clinical trial
gestational age
randomized controlled trial